{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:44:05Z","timestamp":1791380645087,"version":"4.3.3"},"reference-count":36,"publisher":"MedWorks Media","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Objectives\nThe addition of amphetamine to a sedating medication may reduce sedation but does it augment reaction time and sustained attention for workers? The purpose of this exploratory study was gain insight into between group differences that would assist hypothesis formation for a subsequent hypothesis testing study.\nMethods\nThis study examined psychomotor vigilance task (PVT) performance for a group taking potentially sedating medications (opiates, benzodiazepines, anticholinergics, barbiturates or polypharmacy) while taking amphetamine to a group not taking amphetamine. Data was assessed using two-way between groups multivariate analysis of variance.\nResults\nMultivariate testing found a (p = .05; \u03b72 = .044) difference in combined PVT measures between the amphetamine use groups. Tests of between-subjects effects established ( p = .006; \u03b72 = .042) a difference in the number of minor lapses between the groups. Estimated marginal means of minor lapses revealed that the group taking amphetamine had 2.8 times the mean number of minor lapses than the group not taking amphetamine. A non-statistically significant trend was noted for the estimated marginal means of each sedating medication class and the use or nonuse of amphetamines that appears to correspond with the sedating medication\u2019s effect upon the cholinergic component of the attention system.\nConclusion\nUsing PVT data, this exploratory study has provided information useful for generating the hypothesis that co-administration of an amphetamine with a sedating medication will result in arousal with a deficit of sustained attention related to the sedating medication\u2019s level of effect upon cholinergic activity.<\/jats:p>","DOI":"10.64719\/pb.4359","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:39:16Z","timestamp":1761046756000},"page":"22-35","source":"Crossref","is-referenced-by-count":0,"title":["The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention"],"prefix":"10.64719","volume":"47","author":[{"given":"James W.","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"ref1","unstructured":"Centers for Disease Control and Prevention. Opioid Painkiller Prescribing: Where You Live Makes a Difference. 2014 Accessed July 12, 2016."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry. 2015;72(2):136\u2013142.","DOI":"10.1001\/jamapsychiatry.2014.1763"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Price J. Comparison of random and post-accident urine drug tests in southern Indiana coal miners. Journal of Addiction Medicine. 2012;6(4):253\u2013257.","DOI":"10.1097\/ADM.0b013e318266a8d5"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Price J. Benzodiazepines and workplace safety: an examination of urine drug tests. Journal of Addiction Medicine. 2014;8(5):333\u2013337.","DOI":"10.1097\/ADM.0000000000000053"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Price J. A comparison of random and post-accident urine opiate and opioid tests. Journal of Addictive Diseases. 2015;34(1):36\u201342.","DOI":"10.1080\/10550887.2014.975614"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Price J. The difference between random and post-accident urine drug test concentrations among Southern Indiana, Western Kentucky, and Eastern Illinois workers. Journal of Addictive Medicine. 2016;10(6):414\u2013417.","DOI":"10.1097\/ADM.0000000000000254"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Webster L, Andrews M, Stoddard G. Modafinil treatment of opioid-induced sedation. Pain Medicine. 2003;4(2):135\u2013140.","DOI":"10.1046\/j.1526-4637.2003.03014.x"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Bruera E, Brenneis C, Paterson A, MacDonald R. Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. Journal of Pain and Symptom Management. 1989;4(1):3\u20136.","DOI":"10.1016\/0885-3924(89)90057-2"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Yee J, Berde C. Dextroamphetamine or methylphenidate as adjuvants to opioid analgesia for adolescents with cancer. Journal of Pain and Symptom Management. 1994;9(2):122\u2013125.","DOI":"10.1016\/0885-3924(94)90165-1"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Molitch M, Eccles A. The effect of benzedrine sulfate on the intelligence scores of children. American Journal of Psychiatry. 1937;94(3):587\u2013590.","DOI":"10.1176\/ajp.94.3.587"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Bradley C. The behavior of children receiving benzedrine. American Journal of Psychiatry. 1937;94(3):577\u2013585.","DOI":"10.1176\/ajp.94.3.577"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Heal D, Smith S, Gosden J, Nutt D. Amphetamine, past and present-a pharmacological and clinical perspective. Journal of Psychopharmacology. 2013;27(6):479\u2013496.","DOI":"10.1177\/0269881113482532"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Pliszka S. Pharmacologic treatment of attention-deficit\/hyperactivity disorder: efficacy, safety and mechanisms of action. Neuropsychology Review. 2007;17(1):61.","DOI":"10.1007\/s11065-006-9017-3"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Berridge C, Stalnaker T. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex. Synapse. 2002;46(3):140\u2013149.","DOI":"10.1002\/syn.10131"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Boutrel B, Koob G. What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications? Sleep. 2004;27:1181\u20131194.","DOI":"10.1093\/sleep\/27.6.1181"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Koelega H. Stimulant drugs and vigilance performance: a review. Psychopharmacology. 1993;111(1):1\u201316.","DOI":"10.1007\/BF02257400"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Oken B, Salinsky M, Elsas S. Vigilance, alertness, or sustained attention: physiological basis and measurement. Clinical Neurophysiology. 2006;117(9):1885\u20131901.","DOI":"10.1016\/j.clinph.2006.01.017"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"de Wit H, Enggasser J, Richards J. Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology. 2002;27(5):813\u2013825.","DOI":"10.1016\/S0893-133X(02)00343-3"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Newman H. The effect of amphetamine sulfate on performance of normal and fatigued subjects. Journal of Pharmacology and Experimental Therapeutics. 1947;89(2):106\u2013108.","DOI":"10.1016\/S0022-3565(25)05798-2"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ilieva I, Boland J, Farah M. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people. Neuropharmacology. 2013;64:496\u2013505.","DOI":"10.1016\/j.neuropharm.2012.07.021"},{"key":"ref21","unstructured":"Fleming K, Bigelow L, Weinberger D, Goldberg T. Neuropsychological effects of amphetamine may correlate with personality characteristics. Psychopharmacology Bulletin. 1995"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Silber B, Croft R, Papafotiou K, Stough C. The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology. 2006;187(2):154\u2013169.","DOI":"10.1007\/s00213-006-0410-7"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Wardle M, Treadway M, Mayo L, Zald D, de Wit H. Amping up effort: effects of d-amphetamine on human effort-based decision-making. The Journal of Neuroscience. 2011;31(46):16597\u201316602.","DOI":"10.1523\/JNEUROSCI.4387-11.2011"},{"key":"ref24","unstructured":"Drummond S, Bischoff-Grethe A, Dinges D, Ayalon L, Mednick S, Meloy M. The neural basis of the psychomotor vigilance task. Sleep. 2005;28(9):1059."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Silber B, Papafotiou K, Croft R, Ogden E, Swann P, Stough C. The effects of dexamphetamine on simulated driving performance. Psychopharmacology. 2005;179(3):536\u2013543.","DOI":"10.1007\/s00213-004-2061-x"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Pain M, Hibbs A. Sprint starts and the minimum auditory reaction time. Journal of Sports Sciences. 2007;25(1):79\u201386.","DOI":"10.1080\/02640410600718004"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Powell N, Riley R, Schechtman K, Blumen M, Dinges D, Guilleminault C. A comparative model: reaction time performance in sleep-disordered breathing versus alcohol-impaired controls. The Laryngoscope. 1999;109:1648\u20131654.","DOI":"10.1097\/00005537-199910000-00019"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Khitrov M, Laxminarayan S, Thorsley D, Ramakrishnan S, Rajaraman S, Wesensten N et al. PC-PVT: A platform for psychomotor vigilance task testing, analysis, and prediction. Behavior Research Methods. 2014;46(1):140\u2013147.","DOI":"10.3758\/s13428-013-0339-9"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Lee I, Bardwell W, Ancoli-Israel S, Dimsdale J. Number of lapses during the psychomotor vigilance task as an objective measure of fatigue. J Clinical Sleep Medicine. 2010;6(2):163\u2013168.","DOI":"10.5664\/jcsm.27766"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Anderson C, Wales A, Horne J. PVT lapses differ according to eyes open, closed, or looking away. Sleep. 2010;33(2):197\u2013204.","DOI":"10.1093\/sleep\/33.2.197"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Stevens J. Outliers and influential data points in regression analysis. Psychological Bulletin. 1984;95(2):334.","DOI":"10.1037\/0033-2909.95.2.334"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Sarter M, Givens B, Bruno J. The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Research Reviews. 2001;35(2):146\u2013160.","DOI":"10.1016\/S0165-0173(01)00044-3"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Ressler K, Nemeroff C. Role of norepinephrine in the pathophysiology of neuropsychiatric disorders. CNS Spectrums. 2001;6(08):663\u2013670.","DOI":"10.1017\/S1092852900001358"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Rothman R, Baumann M, Dersch C, Romero D, Rice K, Carroll F et al. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 2001;39(1):32\u201341.","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Shoblock J, Maisonneuve I, Glick S. Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex. Neurochemical Research. 2004;29(7):1437\u20131442.","DOI":"10.1023\/B:NERE.0000026409.76261.f3"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Basner M, Dinges D. Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss. Sleep. 2011;34(5):581.","DOI":"10.1093\/sleep\/34.5.581"}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:26:34Z","timestamp":1791314794000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/the-addition-of-amphetamine-to-potentially-sedating-medication-regimens-an-exploratory-investigation-of-the-impact-upon-reaction-time-and-sustained-attention\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.4359","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}